Aurelia De Pauw

Aurelia De Pauw

Company: Tetra Bio-Pharma

Job title: Vice-President Clinical Programs/ Medical Affairs


Aurelia De Pauw holds a master’s degree and Ph.D. in Science from the Gembloux Agro-Bio Tech, University of Liege and the University of Namur, Belgium. She has 13 years experience in preclinical and clinical research. Aurelia is the author of 10 peer-review articles in cellular metabolism and regenerative therapy. Her work in cardiac stem cell therapy was rewarded by the European Society of Cardiology, the Council on Basic Cardiovascular Science and the International Society for Heart Research. After establishing her career in basic sciences and regenerative therapy, she progressed from the laboratory bench to the bedside where she gained an even deeper appreciation of the impact of research on patients and caregivers. Aurelia has extensive experience in numerous therapeutic categories including oncology, drug addiction, endocrinology, dermatology and cardiology, from phase I to phase IV clinical trials. She’s now Vice-President of Clinical Programs and Medical Affairs at Tetra Bio-Pharma Inc., a pharmaceutical company developing cannabinoid-based drugs.


Panel Discussion: Comparing Whole Plant & Synthetic Cannabinoids & Their Potential in Pharmaceuticals 12:00 pm

Click to see the Full Event Guide for more informationRead more

day: Day One

The Future of Inhaled Cannabinoid-Based Medicine in Cancer: An Alternative Treatment to Improve Quality of Life and Pain Management in Advanced Cancer Patients? 2:00 pm

Click to see the Full Event Guide for more informationRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.